ENDS (ENDometriosis & FuSobacterium) Unveiling the Contribution of Fusobacterium Infection to the Development of Endometriosis
- Disease/Condition
- Endometriosis
- Drug/Device/Intervention
- Fusobacterium detection
- Study type
- Interventional
- Intervention type
- diagnostic test
- Primary sponsor
- IRCCS Sacro Cuore Don Calabria di Negrar
- Location
- Negrar, Italy
- Phase
- N/A
- Start date
- Apr 01, 2024
- End date
- Oct 01, 2025
- Enrollment
- 845 participants
Fusobacterium sp presence (Y/N) in endometrial biopsy in women with endometriosis
This will be a clinical interventional longitudinal study, without pharmacological
 intervention/device evaluation.
 
 A control group would however be recruited for secondary objective 1 and 2.
 
 The study is classified as interventional, as Fusobacterium detection is not part of the
 routine management of these patients; from the patients' point of view, participation in the
 study will involve the execution of additional vaginal and cervical swabs as additional
 procedure, while the endometrial biopsy will not represent an additional examination, as the
 study will include only patients for whom this examination is expected as per normal clinical
 practice.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06368596
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT06368596 through Pure Global AI's free database. This phase not specified trial is sponsored by IRCCS Sacro Cuore Don Calabria di Negrar and is currently Not yet recruiting. The study focuses on Endometriosis. Target enrollment is 845 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.